Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Valeant Surges Post Reassessment" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Valeant Surges Post Reassessment for you to read. Along with our medical data and news we also list Valeant Surges Post Reassessment Clinical Trials, which are updated daily. BioPortfolio also has a large database of Valeant Surges Post Reassessment Companies for you to search.
NewLink Genetics (NASDAQ:NLNK) reported today that Merck has begun the submission of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for V920 (rVSV∆G-ZEBOV-GP, live attenuated). As quoted in the press release: This rolling submission is made pursuant to the FDA’s Breakthrough Therapy Designation for V920, which was announced by Merck in July R...
Named after the two-faced god, newly developed Janus nucleic acid recognition elements target double-stranded DNA or RNA by engaging both strands at once. When strung together within a single-stranded protein nucleic acid (PNA), a synthetic construct, Janus elements may bind to natural targets in a sequence-specific manner. What’s more, Janus elements, like Janus himself, looks […] The pos...
Selected as the only orthopedic practice in Ohio to participate in the Zimmer Biomet mymobility Clinical Study COLUMBUS, Ohio (PRWEB) November 15, 2018 Joint Implant Surgeons (JIS), a world leader in outpatient joint replacements and the premier orthopedic institution in the Midwest, is one of only nine group practice centers in the nation to be selected to participate in the Zimmer Biomet mymobi...
Scientists at the Salk Institute have identified a new subclass of anti-aging geroprotector compounds that can slow aging in mice and could represent promising drug candidates for Alzheimer’s disease (AD). Early studies in different rodent models suggest that the compounds, termed geroneuroprotectors (GNPs), improve memory and reduce hallmark toxicities associated with AD. Preclinical studie...
Traditional herbal medicines used for centuries often have tangible physiologic and therapeutic value. Yet, for these remedies to be successful for the masses the underlying cellular and molecular properties need to be carefully teased out and assessed for safety and effectiveness. In that vein, investigators in the department of physiology & biophysics at the University […] The post Her...
Mirror.co.ukSingle mum shares devastating moment she met stillborn baby boy to warn women to 'listen to their bodies'Mirror.co.ukA mum has shared heart-wrenching photos of the moment she gave birth to her stillborn baby boy after his heart stopped beating at 32 weeks. Kristy Watson, from Victoria in Australia, made the decision to post the photos on Facebook in the hope that "no ...Woman shares he...
Yorkshire Evening PostThis is the information your Leeds GP shares about youYorkshire Evening PostYou might trust your GP to take care of you, but do you know how they store your personal information and what they do with it? Each time you receive care from the NHS in Leeds, either at a pharmacy, GP surgery, hospital or any other care setting ...and more
United Therapeutics has acquired exclusive global rights to Arena Pharmaceuticals’ Phase III pulmonary arterial hypertension (PAH) candidate ralinepag (APD811), in a licensing deal that could generate more than $1.2 billion for Arena, the companies said today. Ralinepag (APD811) is a next-generation, oral, selective potent, once-daily prostacyclin receptor (IP) agonist intended for PAH. Accordin...
This blog is written to honor all of the caregivers who give tirelessly of themselves for a loved one and often feel left alone to navigate the healthcare system. I want you to know you are not alone. We in ONC stand with you both professionally and personally as we dedicate our efforts to improving the health and well-being of individuals and communities through the use of technology and health i...
Even though school security is a booming industry, The Washington Post surveyed schools that have had shootings and only one school suggested that any kind of safety technology might have made a difference. Many had robust security plans already in place but still couldn’t stop the incidents. The response is backed up by a federally funded study that cautioned about the effectiveness of school s...
CDC study highlights several factors that can make norovirus outbreaks more severe and may help guide efforts to develop a vaccine. The post Norovirus Genotype Study May Boost Vaccine Efforts appeared first on GEN - Genetic Engineering and Biotechnology News.
Centers for Disease Control and Prevention (CDC) research highlights several factors that can make norovirus outbreaks more severe and may help guide efforts to develop a vaccine. The disease spreads through direct contact with an infected person, consuming contaminated food or water, or touching contaminated surfaces. The post Norovirus Insights May Improve Conditions Below Deck appeared first ...
Phivida Holdings Inc (CSE:VIDA, OTCQX:PHVAF) ("Phivida"), which offers premium beverages and clinical products infused with active hemp extract, today announced its Q4 2018 corporate business update on milestones achieved and strategic initiatives underway. The post Phivida Announces Q4 2018 Corporate Business Update appeared first on Investing News Network.
Despite fears surrounding workplace automation, a third of UK employees (34%) believe a robot would be better at decision making...Read More... The post Workplace automation: 34% of UK employees think a robot would do a better job than their boss appeared first on Pharmaceutical Technology.
There is no excerpt because this is a protected post.
On 14 November, the UK Government published its draft agreement for the withdrawal of the UK from the European Union...Read More... The post Draft Brexit withdrawal agreement: what does it mean for the pharma industry? appeared first on Pharmaceutical Technology.
The Vantage Orian represents a new standard in the premium wide bore 1.5T market with new technology designed to boost productivity, enhance patient comfort and deliver diagnostic clinical The post Canon Medical secures FDA approval for Vantage Orian 1.5T MRI system appeared first on Compelo Medical Devices.
The program, which will go live in July 2019, aims to help reduce mortality, length of stay, and ventilation days while providing patients the care they need, wherever The post Dartmouth-Hitchcock Health collaborates with Philips on tele-ICU program appeared first on Compelo Medical Devices.
Flourish device has secured authorization from the US Food and Drug Administration (FDA) under the humanitarian device exemption (HDE) to treat pediatric esophageal atresia. Esophageal atresia is a The post Cook Medical introduces Flourish pediatric esophageal atresia device in US appeared first on Compelo Medical Devices.
By investigating norovirus outbreaks, US researchers at the University of Rochester in New York hope that the development of a norovirus vaccine will occur... The post Shedding light on norovirus outbreaks appeared first on European Pharmaceutical Review.
Apellis Pharmaceuticals is unlikely to resume its Phase III geographic atrophy (GA) trials by year-end 2018 (YE18) as there is not...Read More... The post Apellis unlikely to resume AMD trial before 2019 appeared first on Pharmaceutical Technology.
One application seeks to include use of ibrutinib in combination with obinutuzumab in previously untreated adults with chronic lymphocytic leukaemia (CLL) and to add long-term follow-up data from The post Janssen applies for expanded approval for IMBRUVICA in Europe appeared first on Pharmaceutical Business review.
Central Minnesota’s premier family eye doctors will begin seeing patients at their new office in Montevideo in November of 2018. (PRWEB) November 15, 2018 In November of 2018, two of Fischer Laser Eye Center’s family eye doctors, Mike Novak, OD, and Tom Lenz, OD, will begin seeing patients at their new Montevideo, MN, office located at 629 Legion Drive, Suite 2, in Fiesta Square. The eye care...
SEA-BCMA is an investigational antibody empowered using Seattle Genetics’ proprietary Sugar Engineered Antibody (SEA) technology designed to enhance antibody dependent cellular cytotoxicity. The target of SEA-BCMA, the cell The post Seattle Genetics begins blood cancer trial with SEA-BCMA appeared first on Pharmaceutical Business review.
The phase 3 Keynote-181 study assessing Keytruda as monotherapy in the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma has achieved a primary endpoint of The post Merck’s Keytruda improves overall survival in phase 3 esophageal cancer trial appeared first on Pharmaceutical Business review.